Top Markets
Coin of the day
Aeterna Zentaris Inc. Aeterna Zentaris Inc.

Aeterna Zentaris Inc.

AEZS
Rang in Aktien #35469
Aeterna Zentaris Inc. operates as a specialized biopharmaceutical company,... Aeterna Zentaris Inc. operates as a specialized biopharmaceutical company, dedicated to the creation and market introduction of both therapeutic drugs and diagnostic tests. Its flagship product, macimorelin, is an orally administered peptidomimetic ghrelin receptor (GHSR-1a) agonist. This compound functions by binding to the GHSR-1a, thereby stimulating the secretion of growth hormone. Macimorelin is employed for diagnosing growth hormone deficiency in both adult and pediatric patients, and is also under investigation for various oncology indications. The drug is marketed commercially under the brand name Macrilen. The company engages in various licensing agreements, prominently with University Wuerzburg. This collaboration encompasses the research, development, manufacture, and commercialization of a prospective COVID-19 vaccine. It also involves developing, producing, and marketing a treatment for neuromyelitis optica spectrum disorder (NMOSD), establishing human 3D intestinal tissue models for infection biology research, and advancing pre-clinical work towards a potential Parkinson's disease therapy. Additionally, Aeterna Zentaris has formed licensing partnerships with Consilient Health Ltd., Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada. Another key collaboration is with The University of Sheffield in the United Kingdom, dedicated to the research, development, manufacturing, and commercialization of parathyroid hormone fusion polypeptides designed to treat primary hypoparathyroidism. Founded in 1990, Aeterna Zentaris Inc. maintains its corporate headquarters in Summerville, South Carolina.
Aktienkurs
$3.97
Zuletzt synchronisiert: 2024-09-03
Marktkapitalisierung
$3.86M
Veränderung (1 Tag)
-1.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Aeterna Zentaris Inc. (AEZS)

Kategorie

Preis AEZS mit Marktkapitalisierung von B
Aeterna Zentaris Inc. Aeterna Zentaris Inc.
AEZS
$3.97
Marktkapitalisierung von Aeterna Zentaris Inc.(AEZS)
Marktkapitalisierung: $3.86M
Mit Stand August 2026 hat Aeterna Zentaris Inc. eine Marktkapitalisierung von $3.86M. Das macht Aeterna Zentaris Inc. laut unseren Daten zum 35469th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Aeterna Zentaris Inc. von 2000 bis 2026
AEZS im Vergleich zu den Top 5 der beliebtesten stocks
Preis für AEZS Vermögenswert B Marktkapitalisierung von B Ergebnisse
Aeterna Zentaris Inc. Aeterna Zentaris Inc.
$5,600,588 $3.86M
$5.452T +141,072,643.41%
Aeterna Zentaris Inc. Aeterna Zentaris Inc.
$4,612,502 $3.86M
$4.490T +116,183,838.09%
Aeterna Zentaris Inc. Aeterna Zentaris Inc.
$4,275,952 $3.86M
$4.162T +107,706,507.35%
Aeterna Zentaris Inc. Aeterna Zentaris Inc.
$3,776,628 $3.86M
$3.676T +95,129,081.22%
Aeterna Zentaris Inc. Aeterna Zentaris Inc.
$2,910,325 $3.86M
$2.833T +73,307,822.15%